Global Neurodiagnostics market (2020 to 2025) - by Product Type, Condition, End-user and Geography - ResearchAndMarkets.com

The "Global Neurodiagnostics market (2020-2025) by Product Type, Condition, End user, Geography and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Neurodiagnostics Market is estimated to be USD 6.8 Bn in 2020 and is expected to reach USD 9.5 Bn by 2025, growing at a CAGR of 7%.

Neurological disorders are increasingly recognized as major causes of death and disability worldwide. Data estimated by the Global Burden of states that neurological disorders were the leading causes of Disability-Adjusted Life Years (DALY), with around 276 Mn deaths worldwide. This shows the need for early diagnosis of neurological disorders. Diagnostics testing procedures and tools are essential ways to diagnose a disorder or any other medical condition. In the case of neurosciences, neurodiagnostic has a wide application base.

Neurodiagnostic tests are usually performed on patients who suffer from conditions related to the central nervous system (brain and the spinal cord). These tests monitor and record the electrical activity of the brain, spinal cord, and peripheral nerves to ensure the early and accurate diagnosis of the disease. The specialized imaging procedures can help in visualizing the changes in brain activity or the amounts of a particular brain chemical to provide more detailed diagnostic information. The most common neurodiagnostic procedures are Electroencephalogram (EEG), Magnetic Resonance Imaging (MRI), and Position Emission Tomography (PET) scan. Many companies related to neurodiagnostic are focusing on the development of innovative products to strengthen their product portfolio and product pipelines.

Factors promoting the growth of the neurodiagnostic markets are the increasing number of neurological disorders, growing number of diagnostic centres, growing advancement in genomics and proteomics, the ability of the devices to monitor patients in ICUs, and rising patient emphasis on early diseases diagnosis.

However, low amounts of regular diagnosis amongst the patients due to the high costs associated with the diagnosis and awareness hinders the growth of this market. Also, the lack of skilled expertise and limitations of EEGs in providing accurate diagnosis may impede the market growth. A surge in the prevalence of neurological disorders, technological developments, an increase in healthcare awareness among people, and an increase in healthcare expenditure may provide numerous opportunities for expansion of the Neurodiagnostics Market.

Market Dynamics

Drivers

• Increasing Incidence of Neurological Diseases
• Growing Adoption of Novel Diagnostic Technologies
• Increasing Patient Emphasis on Effective and Early Disease Diagnosis
• Increasing Number of Diagnostic Centres & Hospitals

Restraints

• High Cost of Diagnosis
• Growing Adoption of Refurbished Neurodiagnostic Systems
• Absense of Regular Diagnosis Activities

Opportunities

• Increasing Application in Clinical Trials
• Technological Advancements and Emerging Markets
• Growing Advancement in Genomics and Proteomics for the Diagnosis of Neurodegenerative Disorders

Trends

• Rise in the Demand for Neuroimaging, In-Vitro Diagnosis, and Neuro-Informatics.
• Increased Use of Cloud Computing Based EEG Devices
• Advances in Genomics and Proteomics for the Diagnosis of Neurodegenerative Disorders

Why buy this report?

• The report offers a comprehensive evaluation of the Global Neurodiagnostics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of COVID-19 on the market is also featured in the report.
• The report also contains the competitive analysis using IGR Competitive Quadrant, the analyst's proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market

Companies Mentioned

• GE Healthcare
• Philips Healthcare
• Siemens Healthineers
• Hitachi, Ltd.
• Canon, Inc.
• Lifelines Neuro Company, LLC
• Natus Medical Incorporated
• F. Hoffmann-La Roche AG
• FUJIFILM Holdings Corporation
• Mitsar Co., Ltd.
• Advanced Brain Monitoring, Inc.
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories
• QIAGEN N.V.
• Nihon Kohden Corporation
• Roche NimbleGen, Inc.
• Agilent Technologies
• BGI
• Eurofins Genomics, Inc.
• GENEWIZ, Inc.
• Macrogen, Inc.
• Ambry Genetics
• Pacific Biosciences Of California, Inc
• Koninklijke Philips N.V.
• ANT Neuro
• FONAR
• Fujirebio
• DRG INSTRUMENTS GMBH
• Tecan Trading AG
• Alpha Omega
• Bruker

For more information about this report visit https://www.researchandmarkets.com/r/4uo81h